Background There is some evidence of an association between inflammation in the
pathogenesis of mental disorders. Soluble urokinase plasminogen activator receptor …

Background There is evidence of increased low grade inflammation (LGI) in schizophrenia
patients. However, the inter-individual variation is large and the association with …

Background: The etiology of schizophrenia remains largely unknown but alterations in the
immune system may be involved. In addition to the psychiatric symptoms, schizophrenia is …

Inflammatory abnormalities have been shown in the pathogenesis of schizophrenia. Soluble
urokinase-type plasminogen activator receptor (suPAR) is a protein that is measurable in the …

Introduction Inflammation has been associated with depression and differential
antidepressant (AD) treatment response. Soluble urokinase plasminogen activator receptor …

Objectives Inflammation is involved in the pathogenesis of depression. A few cross-sectional
population-based studies have found that depression is associated with increased levels of …

The soluble form of the urokinase receptor, suPAR, has been suggested as a novel
biomarker of low-grade inflammation. Activation of the immune system has been proposed …

Background The plasma level of the inflammatory biomarker soluble urokinase plasminogen
activator receptor (suPAR) is a strong predictor of disease development and premature …

Introduction In recent years, the role of inflammation in the pathogenesis of Bipolar Disorder
(BD) has been studied thoroughly. Urokinase-type plasminogen activator receptor (uPAR) is …

Background While the molecular underpinnings of vascular dysfunction in psychosis are
under active investigation, their implications remain unclear due to inconsistent and …